Castle Biosciences Inc. (CSTL)

NASDAQ: CSTL · Real-Time Price · USD

19.85

-0.24 (-1.19%)

At close: Apr 29, 2025, 3:59 PM

19.85

0.00%

After-hours: Apr 29, 2025, 04:05 PM EDT

Castle Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	18.25M	-57.47M	-67.14M	-31.29M	-10.28M	5.28M	-6.37M	-12.37M
Depreciation & Amortization	16M	12.33M	10.54M	3.41M	472K	358K	323.02K	310.82K
Stock-Based Compensation	50.32M	51.22M	36.32M	21.74M	8.31M	1.25M	293.64K	108.7K
Other Working Capital	3.08M	6.55M	7.31M	384K	8.3M	738K	1.43M	-467.65K
Other Non-Cash Items	-6.97M	-4.86M	-19.5M	33.04M	823K	2.37M	542.37K	520.23K
Deferred Income Tax	1.4M	-223K	-1.88M	-8.74M	1.4M	-2.28M	272.42K	-163.29K
Change in Working Capital	-14.13M	-6.63M	-7K	-4.1M	9.15M	44K	-7.36M	-640.51K
Operating Cash Flow	64.87M	-5.63M	-41.66M	-18.98M	9.87M	7.01M	-12.29M	-12.23M
Capital Expenditures	-28.33M	-13.62M	-5.63M	-3.48M	-4.75M	-937K	-277.04K	-494.85K
Cash Acquisitions	n/a	n/a	-26.97M	-63.18M	3K	n/a	n/a	n/a
Purchase of Investments	-205.73M	-189.07M	-134.69M	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	183.9M	186.5M	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	18K	13K	742K	10K	3K	n/a	n/a	n/a
Investing Cash Flow	-50.14M	-16.18M	-166.54M	-66.66M	-4.75M	-937K	-277.04K	-494.85K
Debt Repayment	9.9M	-142K	-122K	-8K	-27.36M	20.92M	5.42M	8.57M
Common Stock Repurchased	n/a	-5.13M	-1.69M	-781K	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-3.76M	-2.16M	1.64M	5.43M	3.21M	1.39M	n/a	3.55K
Financial Cash Flow	6.14M	-2.3M	1.51M	5.42M	305.89M	88.29M	15.84M	8.87M
Net Cash Flow	20.87M	-24.11M	-206.69M	-80.22M	311.01M	94.37M	3.27M	-3.86M
Free Cash Flow	36.54M	-19.25M	-47.29M	-22.47M	5.11M	6.08M	-12.57M	-12.73M